EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Novel Mutations in Titin Exon 363 With Different Phenotypes Including a Founder Mutation in Eastern Europe

Veronica Sian iD, Maria Francesca Di Feo, Sergei Kurbatov, Anna Vihola, Helena Luque, Fedor Konovalov, Stojan Peric iD, Cathrina Duffy, Cornelia Kornblum, Kristl G Claeys iD, Peter Hackman, Bjarne Udd und 1 weitere

European Journal of Neurology · 2025

DOI: 10.1111/ene.70433 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Neurology, 2025. Verfasst von Veronica Sian und 12 weiteren Autor:innen. Beteiligte Einrichtung: Folkhälsan Research Center, Helsinki, Finland. Hauptthemen laut MEDLINE: Connectin, Exons, Mutation, Founder Effect. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Academy of Finland, European Union (Compass-NMD), Samfundet Folkhälsan i Svenska Finland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Titin, the largest human protein, is essential for sarcomere structure and function. The TTN gene, spanning 364 exons, undergoes extensive alternative splicing thus producing multiple isoforms. The M‐band region, encoded by exons 359–364, plays a critical role in sarcomere integrity and mechanical stability. Exon 363 is of interest due to its involvement in titinopathies. Pathogenic truncating variants in this exon have been linked to recessive myopathies, including and mainly young‐onset recessive distal titinopathy.

Methods

A multicenter study was conducted on six patients from five unrelated families with confirmed recessive titinopathy and truncating variants in exon 363. Clinical evaluations were performed. Genetic testing and segregation analysis confirmed the phase of the variants.

Results

A novel truncating variant c.107578C>T, p.(Gln35860Ter) was identified in four unrelated patients of Eastern European ancestry, all carrying a second pathogenic variant in a canonical TTN exon. These patients exhibited juvenile/young‐adult onset recessive distal titinopathy with progressive lower limb weakness, frequently asymmetric muscle involvement, and no cardiac or respiratory complications. A Belgian family presented with a congenital myopathy caused by a novel frameshift deletion c.107430delA, p.(Ser35811AlafsTer32) in exon 363, in compound heterozygosity with a truncating variant in exon 208. These patients showed a more severe phenotype.

Conclusions

This study expands the spectrum of TTN‐related myopathies, emphasizing exon 363's pathogenic significance. Truncating exon 363 variants contribute to young onset recessive distal and sometimes early onset titinopathy with contractures, and the phenotype severity is influenced by the second variant's location and exon usage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ConnectinExonsMutationFounder EffectHumansMaleFemalePhenotypeAdultAdolescentPedigreeYoung AdultChild

Stichwörter der Autor:innen

M‐bandcongenital myopathyfounder mutationrecessive distal myopathytitin

Substanzen

ConnectinTTN protein, human

Autor:innen und Institutionen

  • Folkhälsan Research Center, Helsinki, Finland.
  • Department of Medical and Clinical Genetics, Medicum, University of Helsinki, Helsinki, Finland.
  • Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, and Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
  • Research Institute of Experimental Biology and Medicine, Voronezh State Medical University N.N. Burdenko, Voronezh, Russia.
  • Department of Neurology Named After K.N. Tretyakov, Saratov State Medical University Named After V.I. Razumovsky, Saratov, Russia.
  • Laboratory of Genetics, HUS Diagnostic Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

ORCID-Profile: Veronica Sian, Stojan Peric, Kristl G Claeys

Förderung

  • Academy of Finland
  • European Union (Compass-NMD)
  • Samfundet Folkhälsan i Svenska Finland
  • European Joint Program on Rare Diseases (project IDOLS-G)
  • Sigrid Juséliuksen Säätiö
  • European Commission

Zitieren

APA

Sian, V., Di Feo, M. F., Kurbatov, S., Vihola, A., Luque, H., Konovalov, F., Peric, S., Duffy, C., Kornblum, C., Claeys, K. G., Hackman, P., Udd, B., & Savarese, M. (2025). Novel Mutations in Titin Exon 363 With Different Phenotypes Including a Founder Mutation in Eastern Europe. European Journal of Neurology. https://doi.org/10.1111/ene.70433

Vancouver

Sian V, Di Feo MF, Kurbatov S, Vihola A, Luque H, Konovalov F, et al. Novel Mutations in Titin Exon 363 With Different Phenotypes Including a Founder Mutation in Eastern Europe. European Journal of Neurology. 2025. doi:10.1111/ene.70433

BibTeX
@article{Sian2025,
  author = {Sian, Veronica and Di Feo, Maria Francesca and Kurbatov, Sergei and Vihola, Anna and Luque, Helena and Konovalov, Fedor and Peric, Stojan and Duffy, Cathrina and Kornblum, Cornelia and Claeys, Kristl G and Hackman, Peter and Udd, Bjarne and Savarese, Marco},
  title = {Novel Mutations in Titin Exon 363 With Different Phenotypes Including a Founder Mutation in Eastern Europe},
  journal = {European Journal of Neurology},
  year = {2025},
  doi = {10.1111/ene.70433}
}
Kostenlos starten →